Incyte Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (43)

Latest Posts

About This Stock More About This Stock
Insights On Incyte Corporation
Article By: MoneyShow.com
Saturday, June 4, 2022 6:03 PM EDT
In the first quarter of 2022, Incyte Pharmaeuticals reported very strong quarterly results, highlighted by the launch of Opzelura. The launch continues to perform well, with Q1'22 sales of $13 million beating the consensus estimate of $11 million.
In this article: INCY
Read
For Hedge Funds, This Is The Worst 6 Months Since The Financial Crisis: Here's Why
Article By: Tyler Durden
Saturday, August 21, 2021 10:46 PM EDT
The core issues behind recent (and continuing) hedge fund under- performance: concentration, crowding and turnover.
In this article: INCY, BRK-B, MA, MCHI, TDG, V, WFC, BIDU, AAPL, AMZN, EXPE, MSFT, BABA, FB, GOOGL, JD, PYPL, WLTW, UAA, SE, BILI, DIDI
Read
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Article By: StockNews
Monday, June 14, 2021 12:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
In this article: AZN, INCY, AMGN Also: SPY, CNCR
Read
Incyte Q2 Earnings And Revenues Beat Estimates
Article By: Zacks Investment Research
Tuesday, August 4, 2020 9:55 AM EDT
Incyte came out with quarterly earnings of $1.24 per share.
In this article: INCY
Read
4 Biotech Stocks That Could Keep Beating Wall Street
Article By: Zacks Investment Research
Monday, November 11, 2019 1:41 PM EDT
The size of the biotechnology market was valued at $399.4 billion in 2017 and is expected to witness a compound annual growth rate of 9.9% during the forecast period 2018-2024. Here are four stock choises.
In this article: ACAD, INCY, CHRS, BIIB Also: BMY, LLY, ADPT, CELG, TAK, ALEC, NGM
Read

Latest Tweets for $INCY

No tweets yet!

PARTNER HEADLINES